{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:13:03Z","timestamp":1740154383094,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ADHD Atten Def Hyp Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s12402-018-0264-y","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T21:53:01Z","timestamp":1535579581000},"page":"317-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ADHD symptoms in a young patient with central diabetes insipidus"],"prefix":"10.1007","volume":"10","author":[{"given":"Irene","family":"Dupong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Guilmin-Crepon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8757-0783","authenticated-orcid":false,"given":"Peyre","family":"Hugo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"264_CR1","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","year":"2013","unstructured":"American Psychiatric Association, American Psychiatric Association (ed) (2013) Diagnostic and statistical manual of mental disorders: DSM-5, 5th edn. American Psychiatric Association, Washington, DC","edition":"5"},{"key":"264_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/pcn.12415","volume":"70","author":"A Bilgi\u00e7","year":"2016","unstructured":"Bilgi\u00e7 A, Toker A, Uysal S (2016) Exploratory study to evaluate plasma vasopressin and apelin-13 levels in children with attention-deficit hyperactivity disorder. Psychiatry Clin Neurosci 70:442\u2013447. \n                    https:\/\/doi.org\/10.1111\/pcn.12415","journal-title":"Psychiatry Clin Neurosci"},{"key":"264_CR3","first-page":"893","volume":"4","author":"K Blum","year":"2008","unstructured":"Blum K, Chen AL-C, Braverman ER et al (2008) Attention-deficit-hyperactivity disorder and reward deficiency syndrome. Neuropsychiatr Dis Treat 4:893\u2013918","journal-title":"Neuropsychiatr Dis Treat"},{"key":"264_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0079-6123(08)61595-2","volume":"119","author":"J Born","year":"1998","unstructured":"Born J, Pietrowsky R, Fehm HL (1998) Neuropsychological effects of vasopressin in healthy humans. Prog Brain Res 119:619\u2013643","journal-title":"Prog Brain Res"},{"key":"264_CR5","doi-asserted-by":"crossref","unstructured":"Brook CGD, Clayton PE, Brown RS, Wiley InterScience (Online service) (2009) Brook\u2019s clinical pediatric endocrinology. Wiley-Blackwell, Hoboken","DOI":"10.1002\/9781444316728"},{"key":"264_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.psyneuen.2005.06.001","volume":"31","author":"J Bruins","year":"2006","unstructured":"Bruins J, Kov\u00e1cs GL, Abbes AP et al (2006) Minor disturbances in central nervous system function in familial neurohypophysial diabetes insipidus. Psychoneuroendocrinology 31:80\u201391. \n                    https:\/\/doi.org\/10.1016\/j.psyneuen.2005.06.001","journal-title":"Psychoneuroendocrinology"},{"key":"264_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1006\/frne.1993.1009","volume":"14","author":"D Wied de","year":"1993","unstructured":"de Wied D, Diamant M, Fodor M (1993) Central nervous system effects of the neurohypophyseal hormones and related peptides. Front Neuroendocrinol 14:251\u2013302. \n                    https:\/\/doi.org\/10.1006\/frne.1993.1009","journal-title":"Front Neuroendocrinol"},{"volume-title":"ADHD rating scale-IV: checklists, norms, and clinical interpretation","year":"1998","key":"264_CR8","unstructured":"DuPaul GJ (ed) (1998) ADHD rating scale-IV: checklists, norms, and clinical interpretation. Guilford Press, New York"},{"key":"264_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.yhbeh.2011.12.014","volume":"61","author":"RP Ebstein","year":"2012","unstructured":"Ebstein RP, Knafo A, Mankuta D et al (2012) The contributions of oxytocin and vasopressin pathway genes to human behavior. Horm Behav 61:359\u2013379. \n                    https:\/\/doi.org\/10.1016\/j.yhbeh.2011.12.014","journal-title":"Horm Behav"},{"key":"264_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neulet.2003.11.050","volume":"356","author":"N Egashira","year":"2004","unstructured":"Egashira N, Tanoue A, Higashihara F et al (2004) V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze. Neurosci Lett 356:195\u2013198. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2003.11.050","journal-title":"Neurosci Lett"},{"key":"264_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0031-9384(94)90022-1","volume":"55","author":"M Engelmann","year":"1994","unstructured":"Engelmann M, Landgraf R (1994) Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats. Physiol Behav 55:145\u2013149","journal-title":"Physiol Behav"},{"key":"264_CR12","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.biopsych.2004.11.024","volume":"57","author":"SV Faraone","year":"2005","unstructured":"Faraone SV, Perlis RH, Doyle AE et al (2005) Molecular genetics of attention-deficit\/hyperactivity disorder. Biol Psychiatry 57:1313\u20131323. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2004.11.024","journal-title":"Biol Psychiatry"},{"key":"264_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejphar.2007.11.063","volume":"583","author":"E Frank","year":"2008","unstructured":"Frank E, Landgraf R (2008) The vasopressin system\u2014from antidiuresis to psychopathology. Eur J Pharmacol 583:226\u2013242. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2007.11.063","journal-title":"Eur J Pharmacol"},{"key":"264_CR14","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1098\/rstb.2006.1939","volume":"361","author":"EAD Hammock","year":"2006","unstructured":"Hammock EAD, Young LJ (2006) Oxytocin, vasopressin and pair bonding: implications for autism. Philos Trans R Soc Lond B Biol Sci 361:2187\u20132198. \n                    https:\/\/doi.org\/10.1098\/rstb.2006.1939","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"264_CR15","volume-title":"Essentials of neuropsychological assessment","author":"N Hebben","year":"2009","unstructured":"Hebben N, Milberg W (2009) Essentials of neuropsychological assessment. Wiley, New York"},{"key":"264_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/(SICI)1096-8628(19960102)61:1<81::AID-AJMG17>3.0.CO;2-S","volume":"61","author":"JA Hoekstra","year":"1996","unstructured":"Hoekstra JA, van Lieburg AF, Monnens LA et al (1996) Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet 61:81\u201388. \n                    https:\/\/doi.org\/10.1002\/(SICI)1096-8628(19960102)61:1%3c81:AID-AJMG17%3e3.0.CO;2-S","journal-title":"Am J Med Genet"},{"key":"264_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neubiorev.2017.01.034","volume":"76","author":"ZV Johnson","year":"2017","unstructured":"Johnson ZV, Young LJ (2017) Oxytocin and vasopressin neural networks: implications for social behavioral diversity and translational neuroscience. Neurosci Biobehav Rev 76:87\u201398. \n                    https:\/\/doi.org\/10.1016\/j.neubiorev.2017.01.034","journal-title":"Neurosci Biobehav Rev"},{"key":"264_CR18","volume-title":"Psychological testing: principles, applications, & issues","author":"RM Kaplan","year":"2013","unstructured":"Kaplan RM, Saccuzzo DP (2013) Psychological testing: principles, applications, & issues, 8th edn. Wadsworth, Cengage Learning, Belmont","edition":"8"},{"key":"264_CR19","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/archgenpsychiatry.2012.271","volume":"69","author":"RG Klein","year":"2012","unstructured":"Klein RG, Mannuzza S, Olazagasti MAR et al (2012) Clinical and functional outcome of childhood attention-deficit\/hyperactivity disorder 33 years later. Arch Gen Psychiatry 69:1295. \n                    https:\/\/doi.org\/10.1001\/archgenpsychiatry.2012.271","journal-title":"Arch Gen Psychiatry"},{"key":"264_CR20","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1530\/acta.0.1150392","volume":"115","author":"F Laczi","year":"1987","unstructured":"Laczi F, L\u00e1szl\u00f3 FA, Kov\u00e1cs GL et al (1987) Differential effect of desglycinamide9-(Arg8)-vasopressin on cognitive functions of diabetes insipidus and alcoholic patients. Acta Endocrinol (Copenh) 115:392\u2013398","journal-title":"Acta Endocrinol (Copenh)"},{"key":"264_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1192\/bjp.bp.109.066274","volume":"196","author":"K Langley","year":"2010","unstructured":"Langley K, Fowler T, Ford T et al (2010) Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder. Br J Psychiatry 196:235\u2013240. \n                    https:\/\/doi.org\/10.1192\/bjp.bp.109.066274","journal-title":"Br J Psychiatry"},{"key":"264_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ambp.2006.05.005","volume":"7","author":"IM Loe","year":"2007","unstructured":"Loe IM, Feldman HM (2007) Academic and educational outcomes of children with ADHD. Ambul Pediatr Off J Ambul Pediatr Assoc 7:82\u201390. \n                    https:\/\/doi.org\/10.1016\/j.ambp.2006.05.005","journal-title":"Ambul Pediatr Off J Ambul Pediatr Assoc"},{"key":"264_CR23","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.biopsych.2004.10.011","volume":"57","author":"BK Madras","year":"2005","unstructured":"Madras BK, Miller GM, Fischman AJ (2005) The dopamine transporter and attention-deficit\/hyperactivity disorder. Biol Psychiatry 57:1397\u20131409. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2004.10.011","journal-title":"Biol Psychiatry"},{"key":"264_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn3044","volume":"12","author":"A Meyer-Lindenberg","year":"2011","unstructured":"Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M (2011) Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 12:524\u2013538. \n                    https:\/\/doi.org\/10.1038\/nrn3044","journal-title":"Nat Rev Neurosci"},{"key":"264_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.chc.2007.11.011","volume":"17","author":"E Mick","year":"2008","unstructured":"Mick E, Faraone SV (2008) Genetics of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 17:261\u2013284. \n                    https:\/\/doi.org\/10.1016\/j.chc.2007.11.011","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"264_CR26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.mehy.2007.01.081","volume":"69","author":"K Nabe","year":"2007","unstructured":"Nabe K, Honjo S, Ikeda H et al (2007) Diabetes insipidus and cognitive function. Med Hypotheses 69:764\u2013766. \n                    https:\/\/doi.org\/10.1016\/j.mehy.2007.01.081","journal-title":"Med Hypotheses"},{"key":"264_CR27","unstructured":"Porter RS, Kaplan JL, Merck & Co (2011) The Merck manual of diagnosis and therapy. Merck Sharp & Dohme Corp., Whitehouse Station"},{"key":"264_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ejphar.2007.11.074","volume":"583","author":"M Raggenbass","year":"2008","unstructured":"Raggenbass M (2008) Overview of cellular electrophysiological actions of vasopressin. Eur J Pharmacol 583:243\u2013254. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2007.11.074","journal-title":"Eur J Pharmacol"},{"key":"264_CR29","first-page":"107","volume":"58","author":"S Rittig","year":"1996","unstructured":"Rittig S, Robertson GL, Siggaard C et al (1996) Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am J Hum Genet 58:107\u2013117","journal-title":"Am J Hum Genet"},{"key":"264_CR30","doi-asserted-by":"publisher","first-page":"85R","DOI":"10.1203\/PDR.0b013e318212f562","volume":"69","author":"DH Skuse","year":"2011","unstructured":"Skuse DH, Gallagher L (2011) Genetic influences on social cognition. Pediatr Res 69:85R\u201391R. \n                    https:\/\/doi.org\/10.1203\/PDR.0b013e318212f562","journal-title":"Pediatr Res"},{"key":"264_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/sj.mp.4000354","volume":"3","author":"JM Swanson","year":"1998","unstructured":"Swanson JM, Sunohara GA, Kennedy JL et al (1998) Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 3:38\u201341. \n                    https:\/\/doi.org\/10.1038\/sj.mp.4000354","journal-title":"Mol Psychiatry"},{"key":"264_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00238-X","author":"A Thapar","year":"2015","unstructured":"Thapar A, Cooper M (2015) Attention deficit hyperactivity disorder. Lancet. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(15)00238-X","journal-title":"Lancet"},{"key":"264_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/YPG.0b013e32832a0b2b","volume":"19","author":"D West Van","year":"2009","unstructured":"Van West D, Del-Favero J, Deboutte D et al (2009) Arginine vasopressin receptor gene-based single-nucleotide polymorphism analysis in attention deficit hyperactivity disorder. Psychiatr Genet 19:102\u2013103. \n                    https:\/\/doi.org\/10.1097\/YPG.0b013e32832a0b2b","journal-title":"Psychiatr Genet"},{"key":"264_CR34","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jama.2009.1308","volume":"302","author":"ND Volkow","year":"2009","unstructured":"Volkow ND, Wang G-J, Kollins SH et al (2009) Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA 302:1084\u20131091. \n                    https:\/\/doi.org\/10.1001\/jama.2009.1308","journal-title":"JAMA"},{"volume-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","year":"1992","key":"264_CR35","unstructured":"World Health Organization (ed) (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva"}],"container-title":["ADHD Attention Deficit and Hyperactivity Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12402-018-0264-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12402-018-0264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12402-018-0264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T19:48:49Z","timestamp":1567021729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12402-018-0264-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["264"],"URL":"https:\/\/doi.org\/10.1007\/s12402-018-0264-y","relation":{},"ISSN":["1866-6116","1866-6647"],"issn-type":[{"type":"print","value":"1866-6116"},{"type":"electronic","value":"1866-6647"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"29 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Irene Dupong, Dr Guilmin-Crepon, and Dr Peyre declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All of the included subjects gave their written informed consent for this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}